Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
|
|
Edesa Biotech, Inc. (SBOT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Lemieux Stephen (CFO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 17,400 shares
@ $0 |
|
| 08/04/2023 |
4
| Brooks Michael J (President) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 93,200 shares
@ $0 |
|
| 08/04/2023 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 99,300 shares
@ $0 |
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $2.9858, valued at
$6k
|
|
| 03/31/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $3.0491, valued at
$6.1k
|
|
| 03/30/2022 |
4
| Chao Jennifer M (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.94, valued at
$88.2k
|
|
| 03/30/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $3.0168, valued at
$6k
|
|
| 03/21/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $3.8496, valued at
$7.7k
|
|
| 03/18/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 397 shares
@ $3.2498, valued at
$1.3k
Bought 1,603 shares
@ $3.264, valued at
$5.2k
|
|
| 03/16/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $2.799, valued at
$5.6k
|
|
| 03/15/2022 |
4
| Brooks Michael J (President) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 1,250 shares
@ $2.7893, valued at
$3.5k
|
|
| 03/14/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $3.1788, valued at
$6.4k
Bought 5,000 shares
@ $3.0589, valued at
$15.3k
|
|
| 03/11/2022 |
4
| Brooks Michael J (President) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 1,000 shares
@ $3.2229, valued at
$3.2k
|
|
| 03/10/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 1,500 shares
@ $3.0464, valued at
$4.6k
|
|
| 03/09/2022 |
4
| Brooks Michael J (President) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 1,250 shares
@ $2.8975, valued at
$3.6k
|
|
|
|
|